ALVO vs STOK
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
ALVO · Alvotech$4.86 ▲ 6.81%
STOK · Stoke Therapeutics$26.54 ▲ 1.80%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- ALVO -11.3%
- STOK +18.6%
Head to head
| Metric | ALVO | STOK |
|---|---|---|
| Price | $4.86 | $26.54 |
| Change today | ▲ 6.81% | ▲ 1.80% |
| Market cap | $1.73B | $1.74B |
| Return, 3 months | +28.9% | -17.7% |
| Return, year to date | -5.3% | -16.4% |
| Return, 1 year | -14.9% | +16.1% |
| P/E (TTM) | – | – |
| P/B | -8.6 | 4.9 |
| P/E percentile vs own 5y | 24th | 24th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -38.9% | +5.9% |
| Net profit growth (YoY) | -308.6% | -92.0% |
| Gross margin | 60.4% | – |
| Operating margin | 9.7% | -913.2% |
| Net margin | -36.5% | -862.1% |
| Return on equity | – | -73.6% |
| Analyst target vs. price | +57.8% | +69.6% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 47 | 52 |
| 30-day volatility | 67.5% | 47.9% |
| Max drawdown, 1 year | -63.1% | -41.3% |
| Trend read | Leaning bearish | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- STOK is the largest of the group by market value.
- STOK has returned the most over the past year.
- STOK is growing revenue fastest.
- ALVO keeps the most profit per dollar of sales.
- STOK has been the calmest stock over the last 30 days.